After months of 10 p.m. Saturday emails about utilization trends and "pain points" at Community Health Systems, Mark Cuban Cost Plus Drug Co. secured its first hospital system partnership. Compared to other drugmakers, CHS leaders called the relationship unique. 

Since 2020, there has been a 10% growth in pharmacy residency positions in the U.S., the American Society of Health-System Pharmacists said March 13. 

In the first study of three recurrent glioblastoma patients treated with CAR T-cell drugs, researchers discovered strong results, with one 72-year-old man's brain tumor shrinking by 60% within two months. 

The FDA has identified increased mortality rates linked to two CAR-T therapies: Carvykti, made by Janssen Biotech, and Abecma, from Bristol-Myers Squibb K.K.

Pharmacies and healthcare providers may no longer dispense Paxlovid labeled in accordance with the FDA's emergency use authorization, the agency said March 13.

Drug, supply and equipment shortages are the eighth-most urgent patient safety concern, the ECRI said March 11. 

Par Pharmaceutical, an Endo International company, recalled one lot of treprostinil injection solutions because of the potential presence of silicone particles, the FDA said March 12. 

Eli Lilly has tapped Amazon Pharmacy as a partner to deliver select medications including weight loss drugs directly to consumers' homes.

Seattle Children's is the first FDA-authorized site to deliver an experimental CAR T-cell therapy to children with lupus, the system said March 11. 

A new report from Healthsperien, prepared for the American Hospital Association, found that while the 340B program is still a minor portion of the drug industry revenue, its growth has provided significant benefits to a large number of underserved U.S.…